medicaid glp-1 coverage fuels US of Novo, Lilly weight-loss drugs Weight-loss drug coverage extends to

Blue Sky MD offers GLP-1 medication to medically qualified patients

Why it matters: Without lasting behavior changes and healthy habits, many GLP-1 users ultimately end up back where they started

Wegovy is approved for people with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with weight-related conditions

Research shows that patients on higher doses (1.7 mg to 2.4 mg) experience greater average weight loss than those on maintenance doses of 0.5 or 1 mg

In this must-listen episode of the Modern Thyroid and Wellness Podcast, host McCall McPherson sits down with functional medicine expert Dr

GLP-1 has a variety of physiological functions, which can regulate blood glucose level by promoting insulin secretion and synthesis, stimulating -cell proliferation and inducing islet regeneration, inhibiting -cell apoptosis and glucagon release, delaying gastric emptying and controlling appetite (Mller et al., 2019